Get the Stockscreener App
22.32
0.18%
0.04
Tectonic Therapeutic Inc stock is traded at $22.32, with a volume of 155.42K.
It is up +0.18% in the last 24 hours and up +9.68% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$22.28
Open:
$22.38
24h Volume:
155.42K
Relative Volume:
0.77
Market Cap:
$416.77M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.87%
1M Performance:
+9.68%
6M Performance:
-52.25%
1Y Performance:
+31.29%
1-Day Range:
$22.09
$23.00
1-Week Range:
$21.41
$23.61
52-Week Range:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
22.32 | 416.02M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-25 | Initiated | Truist | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
How does Tectonic Therapeutic Inc. compare to its industry peersBreakthrough stock performance - jammulinksnews.com
Competitive Positioning of Tectonic Therapeutic Inc.: Is It Leading or LaggingHigh Win Rate Stock Ideas - Newser
Is Tectonic Therapeutic Inc. stock overvalued or undervaluedAccelerated wealth expansion - jammulinksnews.com
How Tectonic Therapeutic Inc. stock performs during market volatilityTop Momentum Stock Pick - Newser
Is Tectonic Therapeutic Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFast Gains With Reduced Risk - Newser
What are analysts’ price targets for Tectonic Therapeutic Inc. in the next 12 monthsDiscover market opportunities others miss - jammulinksnews.com
What institutions are buying Tectonic Therapeutic Inc. stock nowInvestor Friendly Risk Reward - Newser
What makes Tectonic Therapeutic Inc. stock price move sharplyHigh Return Intraday Picks - Metal.it
Wall Street Zen Downgrades Tectonic Therapeutic (NASDAQ:TECX) to Sell - Defense World
Tectonic Therapeutic Inc. Stock Analysis and ForecastPowerful profit generation - PrintWeekIndia
What analysts say about Tectonic Therapeutic Inc. stock outlookPortfolio Boosting Stock Alerts - Newser
Is Tectonic Therapeutic Inc. a good long term investmentMarket-crushing stock picks - PrintWeekIndia
How high can Tectonic Therapeutic Inc. stock price go in 2025Breakthrough profits - jammulinksnews.com
What analysts say about Tectonic Therapeutic Inc. stockExplosive trading growth - Autocar Professional
What drives Tectonic Therapeutic Inc. stock priceExponential wealth increase - jammulinksnews.com
Tectonic Therapeutic (NASDAQ:TECX) Now Covered by Truist Financial - Defense World
Tectonic Therapeutic, Inc. Rings the Closing Bell - Nasdaq
Truist Securities initiates Tectonic Therapeutics stock with Buy rating - Investing.com
Truist Securities initiates Tectonic Therapeutics stock with Buy rating By Investing.com - Investing.com South Africa
Why Tectonic Therapeutic Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Russell 2000 Implied Analyst Target Price at $269.34, 20.67% Upside to Current Price of $223.21. - AInvest
Tectonic Therapeutic Inc Stock (TECX) Financials Data
There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Tectonic Therapeutic Inc Stock (TECX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
45,858 |
767,204 |
1,449,652 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
21,071 |
311,020 |
1,403,794 |
| SPRINGER TIMOTHY A | Director |
Apr 11 '25 |
Buy |
16.31 |
9,478 |
154,586 |
4,334,846 |
| SPRINGER TIMOTHY A | Director |
Apr 10 '25 |
Buy |
16.73 |
8,092 |
135,379 |
4,325,368 |
| SPRINGER TIMOTHY A | Director |
Apr 09 '25 |
Buy |
14.76 |
3,718 |
54,880 |
4,317,276 |
| SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
412,500 |
7,053,750 |
1,382,723 |
| SPRINGER TIMOTHY A | Director |
Apr 07 '25 |
Buy |
17.10 |
87,500 |
1,496,250 |
4,313,558 |
| MCGUIRE TERRANCE | Director |
Apr 07 '25 |
Sale |
17.10 |
500,000 |
8,550,000 |
573,062 |
| SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
50.00 |
660,000 |
33,000,000 |
970,223 |
| SPRINGER TIMOTHY A | Director |
Feb 05 '25 |
Buy |
54.14 |
129,294 |
6,999,977 |
4,226,058 |
0.97%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):